Literature DB >> 8586687

Coxiella burnetii blood cultures from acute and chronic Q-fever patients.

D Musso1, D Raoult.   

Abstract

Q fever, a worldwide zoonosis caused by Coxiella burnetii, may present as either an acute or a chronic disease. We correlated the results of 844 C. burnetii blood cultures with serological, clinical, and therapeutic data. C. burnetii was isolated from 17% of untreated patients with acute Q fever and from 53% of untreated patients with chronic Q fever. C. burnetii was not isolated from patients who were receiving antibiotics active against C. burnetii. For seven culture-positive patients with acute Q fever, serology was negative when C. burnetii was isolated. One patient with acute Q fever had a positive blood culture 25 days after the discontinuation of specific antibiotic therapy, and another had a positive blood culture after the resolution of symptoms. In one case of chronic Q fever, a positive blood culture resulted from noncompliance with treatment. The culture method described in this report is suitable for all laboratories with cell culture facilities. Our findings suggest that blood samples must be collected prior to the initiation of an antibiotic regimen if C. burnetii is to be successfully isolated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586687      PMCID: PMC228658          DOI: 10.1128/jcm.33.12.3129-3132.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Studies on the bacteremia of bacterial endocarditis.

Authors:  A S Werner; C G Cobbs; D Kaye; E W Hook
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

2.  Q fever during pregnancy--a risk for women, fetuses, and obstetricians.

Authors:  D Racult; A Stein
Journal:  N Engl J Med       Date:  1994-02-03       Impact factor: 91.245

3.  [Clinical aspects observed during an epidemic of 415 cases of Q fever].

Authors:  G Dupuis; O Péter; D Pedroni; J Petite
Journal:  Schweiz Med Wochenschr       Date:  1985-06-15

4.  Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever.

Authors:  O Péter; G Dupuis; W Burgdorfer; M Peacock
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

5.  Serotyping Coxiella burnetii isolates from acute and chronic Q fever patients by using monoclonal antibodies.

Authors:  X Yu; D Raoult
Journal:  FEMS Microbiol Lett       Date:  1994-03-15       Impact factor: 2.742

6.  Humoral immune response to Q fever: enzyme-linked immunosorbent assay antibody response to Coxiella burnetii in experimentally infected guinea pigs.

Authors:  J C Williams; L A Thomas; M G Peacock
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

7.  Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application.

Authors:  E A Shuster; J S Beneke; G E Tegtmeier; G R Pearson; C A Gleaves; A D Wold; T F Smith
Journal:  Mayo Clin Proc       Date:  1985-09       Impact factor: 7.616

8.  Chronic Q fever in hemodialysis patients.

Authors:  F Leonetti; D Raoult; B Dussol; P Brunet; Y Berland
Journal:  Nephron       Date:  1994       Impact factor: 2.847

9.  Pneumonia and meningo-encephalitis due to Coxiella burnetii.

Authors:  T J Marrie
Journal:  J Infect       Date:  1985-07       Impact factor: 6.072

10.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
View more
  33 in total

1.  Isolation in endothelial cell cultures of chlamydia trachomatis LGV (Serovar L2) from a lymph node of a patient with suspected cat scratch disease.

Authors:  M Maurin; D Raoult
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Interlaboratory evaluation of different extraction and real-time PCR methods for detection of Coxiella burnetii DNA in serum.

Authors:  Jeroen J H C Tilburg; Willem J G Melchers; Annika M Pettersson; John W A Rossen; Mirjam H A Hermans; Erik J van Hannen; Marrigje H Nabuurs-Franssen; Maaike C de Vries; Alphons M Horrevorts; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

Review 3.  Chronic Q fever in the United States.

Authors:  Petros C Karakousis; Michele Trucksis; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Seroprevalence of Coxiella burnetii antibodies among students of the Faculty of Medicine in Kosice (Slovakia).

Authors:  E Dorko; Z Kalinová; E Pilipcinec
Journal:  Folia Microbiol (Praha)       Date:  2009-04-18       Impact factor: 2.099

Review 5.  Diagnosis of Q fever.

Authors:  P E Fournier; T J Marrie; D Raoult
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

6.  Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses.

Authors:  B La Scola; G Michel; D Raoult
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Clinical evaluation of a new PCR assay for detection of Coxiella burnetii in human serum samples.

Authors:  G Q Zhang; S V Nguyen; H To; M Ogawa; A Hotta; T Yamaguchi; H J Kim; H Fukushi; K Hirai
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

8.  Pathologic changes during acute Q fever: influence of the route of infection and inoculum size in infected guinea pigs.

Authors:  B La Scola; H Lepidi; D Raoult
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Isolation of Francisella tularensis by centrifugation of shell vial cell culture from an inoculation eschar.

Authors:  P E Fournier; L Bernabeu; B Schubert; M Mutillod; V Roux; D Raoult
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 10.  Q fever in Bulgaria and Slovakia.

Authors:  V S Serbezov; J Kazár; V Novkirishki; N Gatcheva; E Kovácová; V Voynova
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.